首页> 外文期刊>European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) >Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis.
【24h】

Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis.

机译:鼻息肉病患者鼻分泌物中嗜酸性阳离子蛋白水平的临床意义。

获取原文
获取原文并翻译 | 示例
       

摘要

Nasal polyps are characterized by eosinophilic infiltration, and frequently coexist with asthma, aspirin intolerance and allergy. Eosinophilic cationic protein (ECP) is a specific eosinophil granule protein released upon activation of eosinophils. We investigated the ECP levels in nasal secretions of patients with nasal polyposis (NP) in order to correlate them with disease severity and associated diseases and to compare ECP levels between patients with and without recurrence of NP after surgical treatment. A total of 78 patients who had surgery for NP were followed up for a minimum of 18 months. The presence of asthma, allergies or aspirin intolerance was noted. Nasal secretions were obtained 1 day before the surgery and during the follow-up period after surgery. Immunoassays were used to quantify ECP in nasal secretions and serum and interleukin (IL)-5 in nasal secretions. ECP levels in nasal secretions were higher in patients with asthma or aspirin intolerance than in patients without asthma or aspirin intolerance, while no significant differences were found between allergic and non-allergic patients. ECP levels in nasal secretions correlated significantly with IL-5 levels in nasal secretions, the degree of tissue eosinophilia and computed tomographic (CT) scores. In total, 30 patients (38%) developed recurrent NP during the follow-up period. Preoperative ECP and IL-5 levels in nasal secretions were significantly higher in patients with recurrence compared to patients without recurrence. During the follow-up period, patients without recurrence demonstrated a significant reduction in the ECP levels in nasal secretions, whereas there was no significant reduction in the ECP levels of patients with recurrence. The results of this study provide evidence that ECP levels in nasal secretions of patients with NP correlate with the presence of asthma or aspirin intolerance and severity of NP determined by CT scores.
机译:鼻息肉的特征在于嗜酸性粒细胞浸润,并经常与哮喘,阿司匹林不耐受和过敏并存。嗜酸性阳离子蛋白(ECP)是一种在激活嗜酸性粒细胞后释放的特异性嗜酸性粒状蛋白质。我们调查了鼻息肉病(NP)患者鼻分泌物中的ECP水平,以将其与疾病严重程度和相关疾病相关联,并比较手术治疗后有和无NP复发的患者之间的ECP水平。总共78例接受NP手术的患者接受了至少18个月的随访。注意到存在哮喘,过敏或阿司匹林不耐受。鼻腔分泌物在手术前1天和手术后的随访期内获得。免疫测定法用于定量鼻分泌物中的ECP以及鼻分泌物中的血清和白介素(IL)-5。有哮喘或阿司匹林耐受性的患者鼻分泌物的ECP水平高于没有哮喘或阿司匹林耐受性的患者,而过敏和非过敏患者之间无显着差异。鼻分泌物中的ECP水平与鼻分泌物中的IL-5水平,组织嗜酸性粒细胞增多程度和计算机断层扫描(CT)评分显着相关。在随访期间,总共30例患者(38%)出现了复发性NP。与未复发的患者相比,复发患者的鼻腔分泌物的术前ECP和IL-5水平明显更高。在随访期间,无复发的患者鼻分泌物的ECP水平显着降低,而复发的患者的ECP水平没有显着降低。这项研究的结果提供了证据,即NP患者鼻分泌物中的ECP水平与是否存在哮喘或阿司匹林耐受性以及CT评分确定的NP严重程度有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号